SBIR/STTR Research Award

Rapid, Simple and Cost-Effective Detection of Human Cell Line Contamination

Award identifier f8ad11ca95c889a4ff3a716851cb60643f42a16951cbabc780327508a761669dAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$971,603

Program and phase

SBIR · Phase II

Award year

2019

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Nuprobe Usa, Inc.
Proposal award date
2019-09-01
Contract end date
2021-02-28
UEI
H19WHE8GA644
Solicitation number
PA16-186
Topic code
R

Research abstract

Cell line contamination and misidentification have dramatic repercussions in the field biomedical research, largely contributing to the growing concerns about irreproducible results and posing a significant burden on the global biomedical research budget. While the general awareness about these issues has raised over the last years, current authentication technologies such as short tandem repeat (STR) profiling are often labor intensive, slow, costly and not suited for cancer cell lines, which make it very difficult to reliably and continuously monitor human cell cultures. Profiling single nucleotide polymorphisms (SNPs) would provide a good alternative to STR for monitoring cancer cell cultures, SNPs being less affected by genomic instabilities than STR markers. NuProbe’s blocker displacement amplification (BDA) technology uniquely enables multiplexed rare allele enrichment by PCR. Building upon NuProbe’s BDA technology, we propose to develop a series of highly multiplexed and highly sensitive qPCR-based SNP profiling assays to detect intra-species cross-contaminants present in human cell cultures at low levels (down to 1%). We anticipate these assays to translate into rapid, cost effective, reliable, and easy-to-use cell line contamination detection kits compatible with commonly available qPCR instruments.The goal of the project is to develop new kits for detecting low levels of cross-contaminations in human cell cultures and prevent contamination from leading to irreproducible research results or incorrect scientific conclusions. Current technologies are often labor intensive, slow, costly, and/or not suited for cancer cell lines. Building upon NuProbe’s proprietary technology, we propose to develop rapid, cost effective, reliable, and easy-to-use cell line contamination detection kits that will be compatible with commonly used laboratory instruments.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

4 SBIR/STTR records share this UEI (2018–2019). Reported award amounts total $2,245,903. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.